Speiser D E, Tiercy J M, Rufer N, Chapuis B, Morell A, Kern M, Gmür J, Gratwohl A, Roosnek E, Jeannet M
Division d'Immunologie et d'Allergologie, Hôpital Cantonal Universitaire de Genève, Switzerland.
Bone Marrow Transplant. 1994 Jun;13(6):805-9.
The chance of finding an unrelated bone marrow donor depends on the size of the donor registry, the frequency of the patient's HLA phenotype and the degree of histoincompatibility considered acceptable. We have studied 60 unrelated bone marrow donor searches and the probability of finding a donor when increasing HLA-compatibility requirements were applied. For 21 (35%) of the patients no donor could be identified who was (serologically) matched for all six ABDR antigens. For the remaining 39 (65%), a median of two (range 1-20) blood samples from serologically-matched potential donors was obtained for further analysis. Eighteen (30%) patients appeared to be mismatched with all the pre-selected donors because of DR (sub-)type mismatches detected by oligotyping. A further 7 (12%) patients did not have an MLC and/or cytotoxic T lymphocyte precursor (CTLp) negative donor. Thus, a 'perfectly matched' donor was found for 11 (18%) patients. To find a suitable donor for more patients we propose that many or all the potential donors identified in the various registries for a particular patient are simultaneously evaluated as many of the serologically ABDR-matched donors will appear to be incompatible after high resolution HLA-typing. This strategy will not only allow selection of the best matched donor more rapidly but the consequent use of high resolution typing might also lead to the definition of a certain number of acceptable mismatches.
找到非亲属骨髓供者的几率取决于供者登记库的规模、患者人类白细胞抗原(HLA)表型的出现频率以及可接受的组织不相容程度。我们研究了60例非亲属骨髓供者搜索情况,以及在提高HLA相容性要求时找到供者的概率。21例(35%)患者未能找到与所有六种ABDR抗原(血清学)匹配的供者。对于其余39例(65%)患者,从血清学匹配的潜在供者中获取了中位数为两份(范围1 - 20份)血样用于进一步分析。18例(30%)患者由于寡核苷酸分型检测到DR(亚)型不匹配,似乎与所有预先选择的供者不匹配。另外7例(12%)患者没有混合淋巴细胞培养(MLC)阴性和/或细胞毒性T淋巴细胞前体(CTLp)阴性的供者。因此,仅为11例(18%)患者找到了“完美匹配”的供者。为了为更多患者找到合适的供者,我们建议,对于特定患者在各个登记库中确定的许多或所有潜在供者同时进行评估,因为许多血清学ABDR匹配的供者在高分辨率HLA分型后可能会出现不相容情况。这种策略不仅能更快地选择最匹配的供者,而且随后使用高分辨率分型还可能导致确定一定数量可接受的不匹配情况。